MARKET

CPRX

CPRX

Catalyst Pharmaceuticals Inc
NASDAQ
23.08
-0.02
-0.09%
Closed 19:48 12/04 EST
OPEN
22.85
PREV CLOSE
23.10
HIGH
23.22
LOW
22.56
VOLUME
960.89K
TURNOVER
0
52 WEEK HIGH
26.58
52 WEEK LOW
19.05
MARKET CAP
2.84B
P/E (TTM)
13.47
1D
5D
1M
3M
1Y
5Y
1D
Collegium Pharmaceutical, Inc. (COLL) Hits Fresh High: Is There Still Room to Run?
NASDAQ · 23h ago
Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade)
Seeking Alpha · 1d ago
Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term
NASDAQ · 2d ago
How Do Investors Really Feel About Catalyst Pharmaceuticals Inc?
Benzinga · 3d ago
Weekly Report: what happened at CPRX last week (1124-1128)?
Weekly Report · 4d ago
Catalyst Pharma’s CCO Makes a Significant Stock Sale!
TipRanks · 6d ago
Here's How Much a $1000 Investment in Catalyst Pharmaceutical Made 10 Years Ago Would Be Worth Today
NASDAQ · 11/25 13:30
Catalyst Pharmaceuticals to Participate in Bank of America CNS Therapeutics Virtual Conference
Reuters · 11/24 13:03
More
About CPRX
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing medicines for patients living with rare and difficult-to-treat diseases. The Company markets three drug products: FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone). FIRDAPSE is a treatment for people six years of age or older living with Lambert-Eaton myasthenic syndrome (LEMS). The Company, through its sub-licensee, also offers FIRDAPSE in Canada and Japan. FYCOMPA is a prescription medicine used alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures in people with epilepsy aged four and older and with other medicines to treat primary generalized tonic-clonic seizures in people with epilepsy aged 12 and older. AGAMREE is a corticosteroid with a structure that retains the potent anti-inflammatory effects of traditional corticosteroids used in Duchenne muscular dystrophy.

Webull offers Catalyst Pharmaceuticals Inc stock information, including NASDAQ: CPRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CPRX stock methods without spending real money on the virtual paper trading platform.